Skip to main content

Table 4 Multivariate Cox-regression analysis of connexin expression, hormone receptors and CPS-EG classification in breast cancer patient groups

From: The potential prognostic value of connexin 26 and 46 expression in neoadjuvant-treated breast cancer

Patient group

Parameters

P-value

HR

95% CI

    

Lower

Upper

whole cohort

Cx26post

0.303

0.450

0.098

2.055

 

ERpost

0.050

2,739

0.999

7.504

 

Cx26post

0.157

0.134

0.008

2.173

 

PRpost

0.027

6.509

1.241

34.140

 

CPS EG

0.967

0.000

0.000

1.381E26

EWGBSP TR2b

Cx46post

0.790

4.400

0.844

22.950

 

PRpost

0.115

3.809

0.722

20.111

Sataloff TB

Cx46post

0.226

3.782

0.439

32.600

 

PRpost

0.244

2.791

0.496

15.711

Miller-Payne G3

Cx46post

0.104

3.322

0.782

14.105

 

PRpost

0.075

4.400

0.861

22.481

  1. post: after chemotherapy; HR: hazard ratio; CI: confidence intervals.